Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL155045

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
O=[N+]([O-])c1cc2c(NCCc3ccc(Cl)cc3)ncnc2cc1Cl

Basic Information

ChEMBL ID CHEMBL155045
Phase Preclinical
Structure Type MOL
InChI Key LVERQUAJCNJBGH-UHFFFAOYSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names

Molecular Properties

363.2
MW (Da)
4.50
ALogP
5
HBA
1
HBD
81.0
PSA (Ų)
0.53
QED
0
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C16H12Cl2N4O2
MW 363.20
Aromatic Rings 3
Heavy Atoms 24
NP-Likeness -1.50

Activity Summary

IC50 1 meas. best 5.04

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.04 5.04 9060.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 9060.0 nM 5.04 Inhibition of NF-kappaB activation 19726185

Literature References

PubMed DOI Target Context # Activities
11229767 10.1016/s0960-894x(00)00718-6 ADMET 2
11229767 10.1016/s0960-894x(00)00718-6 T-cell 1
19726185 10.1016/j.bmcl.2009.08.021 Unchecked 1

Data from ChEMBL 36 via Core Engine